Senhwa Biosciences
Pre-clinicalDevelops small molecule therapeutics targeting DNA damage response pathways for oncology applications.
Founded
2008
Focus
Small Molecules
About
Develops small molecule therapeutics targeting DNA damage response pathways for oncology applications.
Funding History
4Total raised: $80M
IPO$30MUndisclosedSep 30, 2021
Series C$25MTaiwan Liposome CompanyJun 15, 2019
Series B$15MTaiwan Liposome CompanyJun 15, 2017
Series A$10MTaiwan Liposome CompanyJun 15, 2015
Company Info
TypePrivate
Founded2008
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile